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Multimorbidity remains an underexplored domain in Indian primary care. We undertook a study to assess the prevalence,
correlates, and outcomes of multimorbidity in primary care settings in India. This paper describes the process of development
and validation of our data collection tool “Multimorbidity Assessment Questionnaire for Primary Care (MAQ-PC).” An iterative
process comprising desk review, chart review, and expert consultationswas undertaken to generate the questionnaire.TheMAQ-PC
contained items on chronic conditions, health care utilization, health related quality of life, disease severity, and sociodemographics.
It was first tested with twelve adults for comprehensibility followed by test-retest reliability with 103 patients from four primary
care practices. For interrater reliability, two interviewers separately administered the questionnaire to sixteen patients. MAQ-
PC displayed strong internal consistency (Cronbach’s alpha: 0.69), interrater reliability (Cohen’s Kappa: 0.78–1), and test-retest
reliability (ICC: 0.970–0.741). Substantial concordance between self-report and physician diagnosis (Scott Kappa: 0.59–1.0) was
observed for listed chronic conditions indicating strong concurrent validity. Nearly 54% had one chronic condition and 23.3% had
multimorbidity. Our findings demonstrate MAQ-PC to be a valid and reliable measure of multimorbidity in primary care practice
and suggest its potential utility in multimorbidity research in India.
1. Introduction
Multimorbidity, the concurrent presence of two or more
chronic conditions in individuals, is emerging as a daunting
health challenge globally with substantial impact on health
care utilization, quality of life, and health outcomes [1, 2]. Fur-
thermore, low and middle income countries (LMICs) with
socioeconomic development and westernization of lifestyle
are no longer immune to this challenge as demonstrated by
the reported high prevalence of multimorbidity in Brazil,
Ghana, Indonesia, and Vietnam [3–5]. Similar to other
LMICs, India, home to one-fourth of the world’s population,
is exhibiting a rising trend of chronic diseases and thus
multimorbidity could be an attendant phenomenon [6–8].
The sheer volume of India’s population with concomitant
magnitude of multimorbidity can place critical demands on
existing health care delivery systems [8]. Contrastingly, mul-
timorbidity is still underexplored in India with the available
evidence beingmostly from secondary data sources, confined
to selected population groups and encompassing few chronic
conditions [9].Thismay not be representative of the realmag-
nitude since measurement methods strongly influence the
observed prevalence ofmultimorbidity thus underscoring the
need for an explicit, validated measurement tool [10].
Our systematic review of multimorbidity studies in the
south of Asia has confirmed the lack of uniformity in
assessment of multimorbidity with the conspicuous absence
of reports from primary care in India [9]. This is a vitally
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important knowledge gap, as primary care constitutes the
scaffold of health care delivery in the country and the com-
plex care needs of multimorbid patients require appropriate
redesigning of primary care services [11]. Moreover, only
prevalence of multimorbidity may not be sufficient to inform
health services as the typology of conditions and severity
level also influence the health care to be delivered and the
subsequent outcomes [11]. Although clinical data retrieved
from patients’ records can yield accurate estimation of mul-
timorbidity, our chart review of four urban primary care
practices found thatmultiple chronic conditions are often not
recorded in practice. Furthermore, unlike western countries,
primary care databases are not routinely maintained in India;
hence extraction of medical records from specialist facilities
will present a skewed picture [12].
Aiming at addressing the aforementioned knowledge
gap, we undertook a study to explore the magnitude of
multimorbidity and its correlates and outcomes in a primary
care setting.
It is expected that this information would help public
health researchers in India and similar settings to estimate
the magnitude and impact of multimorbidity in primary care
practice populations.
2. Design and Methods
Thestudywas undertaken inOdisha, an Indian state (approx-
imate population share of 4% of the total population of India)
with average health indicators and comparable health system
characteristics [13]. Considering the absence of standardized
assessment instruments, with proper medical records being
unavailable, we first developed and contextualized a tool so
as to identify and quantify multimorbidity. We decided to
use patient self-reports to elicit information, as they have
demonstrated predictive ability of real morbidity [14, 15].
We aimed to develop and validate our Multimorbidity
Assessment Questionnaire for Primary Care (MAQ-PC). To
examine multimorbidity in primary care in Indian context,
with no gold standard available, we followed an iterative
process to design a comprehensive tool. This comprised two
phases. The first phase is the development of the question-
naire, selecting the domains and their measurements, trans-
lating the questionnaire to local language for cultural adapt-
ability, and testing its comprehensibility. The second phase
involved reliability and validity testing.The steps are outlined
in Figure 1 (supplementary file in Supplementary Material
available online at http://dx.doi.org/10.1155/2016/6582487).
2.1. Selection and Development of Domains. Following
domains were selected by the research team through
literature review and consultation with an expert group and
six primary care physicians. The expert group comprised
two senior faculty members of the Department of Family
and Community Medicine at the state medical colleges,
two clinicians from the Odisha branch of the Indian
Medical Association (IMA), two diseases control program
managers from the state public health directorate, and four
internationally acclaimed researchers in multimorbidity. It
was decided to select six primary care physicians working
Table 1: List of chronic diseases.
Diseases included
Sl. number Name Questions asked forself-reported doctor diagnosis
(1) Diabetes Yes
(2) Hypertension Yes
(3) Arthritis Yes
(4) Acid peptic disease Yes
(5) Asthma Yes
(6) Heart disease Yes
(7) Stroke Yes
(8) Chronic kidney disease Yes
(9) Chronic liver disease(alcohol) Yes
(10) Chronic back ache Yes
(11) Tuberculosis Yes
(12) Filariasis Yes
(13) Visual difficulty Yes
(14) Deafness Yes
(15) Cancer Yes
(16) Dementia Yes
(17) Epilepsy Yes
(18) Thyroid Yes
Depression was screened by using PHQ-9.
in public and private settings. The three private primary
care facilities were selected in consultation with the Odisha
branch of IMA, while for public primary care facility
selection the state public health department’s advice was
sought. To ensure representativeness, one public facility and
one private facility each from the rural, urban, and tribal
regions were selected.
(1) Multimorbidity Estimation. To measure multimorbidity,
we decided to have an exhaustive list of chronic diseases
commonly prevalent in primary care. We first undertook a
systematic search of the available studies in India and other
south Asian countries to determine if any of them used a
list for the most frequently reported chronic conditions [9].
Next, chart review of four primary care practices (two each
from urban and rural area) was done to add relevant chronic
conditions to the list generated from systematic search. The
draft list was shared with the six primary care physicians who
were requested to indicate how important (marginal or very
severe) they considered each particular chronic disease and
to mention additional diseases to the list, if any. Finally, a
consolidated list of 18 conditions (Table 1) was incorporated
in the questionnaire. To ascertain the presence of chronic
conditions, we used patient self-report [15]. The questions
were phrased to elicit whether the patient had ever been told
by a doctor or any other health care provider that they had
any of the listed chronic health problems. We used simple
vernacular language (Odiya) that could be understood by
individuals without any prior medical knowledge (Have you
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even been diagnosed by a physician with. . .?). In addition to
the self-report, we used the Patient Health Questionnaire-9
to capture undiagnosed depression [16].
(2) Outcomes. To explore the impact of multimorbidity, we
included self-reported severity, health related quality of life,
and health care utilization. We did not include health care
expenditure for the sake of brevity:
(a) Severity Assessment. Functional limitation was
used as proxy for disease severity. For each identified
morbidity, we included a subquestion asking how
much the particular health problem gets in the way of
daily activities (e.g., not at all, a little, or a great deal)
[17].
(b) Health Related Quality of Life (HRQL). To explore
health related quality of life, we included two ques-
tions on self-rated physical and mental health (e.g.,
poor, good, or excellent) and SF-12 (already validated
for Indian population) [18].
(c) Health CareUtilization.To examine the health care
utilization, we included questions that asked about
number of outpatient consultations and inpatient
admissions at different health care facilities in the past
twelve months and medication use for each reported
chronic illness [19].
(3) Covariates. We included age (in completed years),
sex (male/female), place of residence (urban/semiurban/
rural), ethnicity (social caste/tribe), religion (Hinduism/
Islam/Christianity/others), educational level (illiterate/
primary education/high school or secondary education/
graduate and above), marital status (never married/currently
married/separated or divorced/widow or widower), and
annual family income [13].
We hypothesized that the MAQ-PC would identify
patients to havemultimorbidity when they have self-reported
multiple chronic conditions; we expected that the overall
judgment of self-reportedmeasures of multimorbidity would
correlate strongly with physician diagnoses and would also
have high internal consistency with other domains (out-
comes).
2.2. Translation andCultural Adaptation. We followed a stan-
dard process to ensure the quality of translation (Figure 2,
supplementary file). Primary forward translation from inter-
national English into vernacular language (Odiya) was per-
formed by two translators independently according to the
standard WHO protocol [20]. The primary translation was
then evaluated for authenticity by two primary care physi-
cians well versed in both languages. The primary transla-
tors discussed apparent differences between the translated
versions with the research team and then agreement was
reached.
2.3. Expert Consultation, Cognitive Debriefing, and Pretesting.
The primary care physicians and international experts were
consulted to respond to the questionnaire to obtain an initial
impression of how easy the questions were to read out,
understand, and answer and their feedbackwas incorporated.
Next, the instrument was cognitively tested with 12 adults
of diverse ages and socioeconomic strata (six men and six
women) for comprehensibility. Structured interviews were
performed with them to evaluate whether all the items in
the MAQ-PC were understood as intended and to examine
the appropriateness of the questionnaire in the local context.
The responses were evaluated by the research team and
the translation team to check if required information is
being captured or not. Based upon it, the questionnaire
was revised. Next step involved a small scale operational
testing of the questionnaire in one primary health centre to
check the logistic feasibility. The time taken to complete the
questionnaire was around 20–25 minutes.
Based on the cumulative observations of above three
processes, we incorporated few changes in the MAQ-PC. We
added open options for three additional chronic conditions
not enlisted in our questionnaire. Insurance availability and
utilization were added. Since we found difficulty in cap-
turing near exact information for income, we included an
additional measure of socioeconomic status, above poverty
line (APL)/below poverty line (BPL), adopted by the state
government for categorizing people based on income [21].
As the patients expressed difficulty in recalling the year of
diagnosis and chronology of appearance for each chronic
condition, these questions were omitted. An interviewer’s
manual was prepared detailing out the instructions for each
question. The final version of MAQ-PC is described in
Table 2.
2.4. Piloting. We examined the reliability and validity of
MAQ-PC final version through a large scale pilot testing
in four (two public and two private) purposively selected
primary care practices in different cities and regions (rural,
urban, semiurban, and tribal) in the state. Adult patients over
18 years of age attending outpatient clinic of these primary
health care centres were included as study participants. Exit
interview was conducted with eligible patients soon after
their physician consultation. Informed consent to take part
in the interview was obtained from each patient after briefing
them about the study and its objectives. A total of 120 patients
were recruited through a systematic random sampling from
the selected four facilities. Four specially trained nurses
administered the questionnaire to patients and examined the
physician’s prescription.The data collection took place under
the direct supervision of the principal investigator (SP) and
the research team.
All 120 patients were then invited to take part in the
two-day retest. As there was increased likelihood of getting
different responses to the question “disease severity and
activity limitation” because of the treatment or medication,
we confined our retest analyses to day 2. A total of 103 par-
ticipants turned up for the retest and were then administered
the MAQ-PC by the same nurses. For each reported chronic
condition, we examined physicians’ prescriptions and noted
the diagnoses. Additionally, to test interrater or interobserver
reliability, another 16 patients were purposively selected and
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Table 2: Domains, items, and measurement tools in MAQ-PC.
Domain Measure Validation process
Chronic conditions
Diseases
(18 with 3 additional open options)
Close ended question of self-reported doctor diagnosed
diseases, symptoms, and prescription check Scott Kappa value
Depression Patient Health Questionnaire-9
Test-retest reliability
and interrater
reliability
Internal consistency
Medication Close ended question according to expert group
Test-retest reliability
and interrater
reliability
Internal consistency
Health care utilization
Frequency of hospital visits in last one year for any
chronic disease
Open ended question for outpatient visit in last one year
[WHO-SAGE]
Test-retest reliability
and interrater
reliability
Internal consistency
Frequency of inpatient admission in last one year
for any chronic disease Open ended question for hospitalization [WHO-SAGE]
Test-retest reliability
and interrater
reliability
Internal consistency
Number of medicines being taken daily Open ended question for number of medicines taken
Test-retest reliability
and interrater
reliability
Internal consistency
Health related quality of life
Self-rated overall health Scales
Cognitive briefing
Test-retest reliability
and interrater
reliability
Internal consistency
SF-12 Mental componentsPhysical components
Cognitive briefing
Test-retest reliability
and interrater
reliability
Internal consistency
Severity of the disease
Limitation in activities due to health problems Impact of individual chronic disease on activity limitation
Test-retest reliability
and interrater
reliability
Frequency of hospital visits for current disease Adopted fromWHO-SAGE 2010
Test-retest reliability
and interrater
reliability
Sociodemographic
Age of the patient Annual Health Survey, India Internal consistency
Gender Annual Health Survey, India Internal consistency
Marital status Annual Health Survey, India Internal consistency
Education Annual Health Survey, India Internal consistency
Net household income per month Annual Health Survey, India Internal consistency
Socioeconomic status According to the government of Odisha Internal consistency
Religion and social caste Annual Health Survey, India Internal consistency
Health insurance Close ended questionnaire developed Internal consistency
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MAQ-PC was administered to them by two members of
the research team (MAH and SS) within 24 hours. Each
observer was blinded to the results of the other assessment.
The agreementwas checked by the principal investigator (SP).
All data were entered and analysed using Statistical Pack-
age for the Social Sciences version 20 (SPSS Inc., Chicago,
IL). Descriptive statistics were calculated and presented
as proportion, mean, and standard deviation (SD). The
prevalence of multimorbidity was measured in terms of the
presence of twoormore self-reported chronic conditions.The
mean score, interclass correlation coefficient, and Cronbach’s
alpha coefficient for each domain were calculated to examine
the internal consistency using the Kuder-Richardson for-
mula [22]. For interobserver reliability, we determined the
observed agreement between two interviewers using Cohen’s
Kappa statistics [23]. The mean score for each domain was
computed to estimate the Kappa value.The concurrent valid-
ity of MAQ-PC was assessed by testing the hypotheses that
MAQ-PC self-reported morbidity correlates strongly with
diagnosed multimorbidity. The level of concordance (self-
reports and physician’s prescription) for each condition was
calculated using Scott Kappa statistics (prevalence-adjusted
bias-adjusted Kappa).
3. Results
3.1. Sample Characteristics. To assess if our study sample was
representative of the primary care population, we studied key
characteristics of included patients (Table 3, supplementary
file). Out of 103 respondents who participated in test and
retest (86% of first sample), 45% (𝑛 = 46) were female. The
mean age of the study participants was 44.96 ± 5. 32 years
with no significant sex difference (female, 45.9, versus male,
44.2).
3.2. Multimorbidity. Nearly 54% of respondents had at least
one self-reported chronic condition enlisted. The prevalence
of multimorbidity was 23% (male, 22%, versus female, 25%)
and around 10% of respondents had three or more chronic
conditions. Frequently reported chronic conditions were acid
peptic disease (25%), arthritis (17%), hypertension (18%), and
chronic back pain (8%), while stroke, cancer, renal disease,
and depression were reported very less (Figure 1).
3.3. Internal Consistency. The overall consistency of the
MAQ-PC was found to be 0.69 for all 52 items with
Cronbach’s alpha value for individual domain ranging from
0.66 for health related quality of life to 0.89 for depression
(Table 3).
3.4. Interobserver Reliability. Both observers reported similar
prevalence of multimorbidity. We observed a substantial
to almost perfect agreement between the two interviewers.
Lowest agreement was seen for depression (Table 4).
3.5. Test-Retest Reliability. The test-retest reliability score
for each domain is denoted in Table 5. We found strong
test-retest correlation in multimorbidity assessment domain
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Figure 1: Prevalence of chronic conditions.
Table 3: Measure of internal consistency of MAQ-PC.
Domains Number of items Cronbach’salpha coefficient
Sociodemographic 8 0.741
Health care utilization 3 0.651
Chronic diseases 18 0.712
Depression 9 0.891
Disease severity 2 0.671
Health related quality of life 12 0.664
Overall 52 0.693
[ICC: 0.970], followed by quality of life physical component
score [ICC: 0.912] and disease severity [ICC: 0.903]. Lowest
correlation was seen for the item self-rated overall health
[ICC: 0.741].
3.6. Concurrent Validity. The correlations between the self-
report and physician’s prescription are presented in Table 6.
The summative multimorbidity score between the first and
follow-up interviews was strongly correlated thus demon-
strating self-report to be adequately predictive of diagnosed
morbidity. The level of agreement was highest for visual
problem, tuberculosis, and dementia while being moderate
for diabetes and hearing problems.
3.7. Ethical Consideration. The study was conducted in accor-
dancewith theDeclaration ofHelsinki. It was approved by the
Institutional Ethics Committee of Public Health Foundation
of India, New Delhi, and necessary permission was granted
by the Government of Odisha.Written informed consent was
obtained from all respondents following an explanation of the
study’s aims and procedures. Participation was purely volun-
tary and all steps have been taken to ensure confidentiality.
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Table 4: Interobserver reliability (Cohen’s Kappa statistics).
Theoretical construct and facets Observer 1Mean [SD]
Observer 2
Mean [SD] Kappa Strength of agreement
Chronic conditions
Diseases and other health problems 1.61 [0.86] 1.61 [0.86] 1 Nearly perfect agreement
Depression 1.92 [0.88] 1.83 [0.83] 0.784 Moderate agreement
Health care utilization
Frequency of hospital visits in last one year 0.98 [1.46] 0.97 [1.39] 0.921 Substantial agreement
Frequency of inpatient admission in last one year 0.30 [0.61] 0.35 [0.76] 0.874 Substantial agreement
Number of medicines taken 0.46 [0.79] 0.39 [0.68] 0.851 Substantial agreement
Health related quality of life
Self-rated overall health 3.53 [0.68] 3.87 [0.75] 0.812 Substantial agreement
SF-12 mental component score 44.25 [9.64] 45.27 [8.67] 0.791 Moderate agreement
SF-12 physical component score 43.57 [4.72] 43.91 [5.13] 0.786 Moderate agreement
Severity
Limitation in activities due to health problems 7.00 [5.93] 7.12 [6.15] 0.831 Substantial agreement
Multimorbidity
Multimorbidity (≥2 chronic conditions)% 13.16 13.16 1 <0.001
Table 5: Measures of reliability (test-retest reliability) for different domains of MAQ-PC.
Domains 𝑁 TestMean [SD]
Retest
Mean [SD] 𝑃 value of the difference ICC
∗
Chronic conditions 103 1.61 [0.86] 1.60 [0.82] 0.932 0.970
Depression 103 1.92 [0.88] 1.86 [0.84] 0.617 0.817
Health care utilization
Frequency of hospital visits in last one year 103 0.98 [1.46] 0.96 [1.42] 0.920 0.822
Frequency of inpatient admission in last one year 103 0.30 [0.61] 0.33 [0.62] 0.726 0.881
Number of medicines taken 103 0.46 [0.79] 0.49 [0.78] 0.784 0.841
Health related quality of life
Self-rated overall health 103 3.53 [0.68] 3.41 [0.72] 0.220 0.741
SF-12 MCS 103 44.25 [9.64] 43.95 [9.67] 0.823 0.893
SF-12 PCS 103 43.57 [4.72] 43.61 [5.12] 0.953 0.912
Severity of the disease
Limitation in activities due to health problems 103 7.00 [5.93] 6.89 [5.60] 0.891 0.903
Multimorbidity (%) 103 23.03 23.01 0.897 0.963
∗Interclass correlation.
4. Discussion
Information on presence and composition of multimorbid-
ity could inform routine clinical practice and impetus for
research. Since the magnitude of multimorbidity is largely
reliant upon the way it is measured, we designed a compre-
hensive tool, MAQ-PC, to elicit data on self-reported preva-
lence, correlates, and outcomes of multimorbidity in patients
attending primary care practices [24]. The questionnaire
intended tomeasure individuals’ count of chronic conditions,
outcomes (severity, self-rated health, quality of life, physi-
cian consultation, and medications), and sociodemographic
correlates. We found multimorbidity prevalence to be higher
than previously reported findings [24].This is expected, as we
included a larger number of chronic conditions and collected
data from patients attending primary care facility.
In this pilot, theMAQ-PC identified hypertension, arthri-
tis, and acid peptic disease as the most common morbidities,
while stroke, cancer, renal disease, and depression were the
least frequently mentioned morbidities. As health system
characteristics influence the type of conditions patients
would present with, the conditionswhichweremore frequent
could be predominantly diagnosed and treated in primary
care [25]. The extreme low number of morbidities, stroke,
cancer, depression, and renal disease, could be due to the
low prevalence of these conditions in the community and
a small sample size of our pilot [26]. Moreover, some
of these patients might be consulting specialists for their
BioMed Research International 7
Table 6: Concordance between self-reported and physician’s prescription based chronic conditions.
Items Number of cases(𝑛 = 103)
Number of cases according to prescription
(𝑛 = 103) Scott Kappa Strength of agreement
Chronic conditions
Arthritis 26 24 0.71 Substantial agreement
Hypertension 21 20 0.73 Substantial agreement
Diabetes 6 7 0.59 Moderate agreement
Chronic lung disease 7 7 0.69 Substantial agreement
Acid peptic disease 33 32 0.66 Substantial agreement
Thyroid problem 0 0
Heart disease 0 0
Stroke 0 0
Visual problem 11 10 0.95 Nearly perfect agreement
Hearing problem 5 5 0.58 Moderate agreement
Chronic back ache 10 10 0.67 Substantial agreement
Tuberculosis 4 4 1.00 Nearly perfect agreement
Epilepsy 0 0
Chronic kidney disease 0 0
Dementia 4 3 0.85 Nearly perfect agreement
Filariasis 0 0
illnesses, which could be another contributing reason [25].
Interestingly, even though depression was underreported, a
good proportion of undiagnosed patients had higher PHQ-
9 score. This suggests that these patients either have not
attributed much significance to related symptoms or may not
have consulted the physician at all.
We observed the MAQ-PC to exhibit significant test-
retest reliability with a substantial degree of agreement
between self-reported chronic condition and physician diag-
nosis (derived from prescription andmedicine verifications).
Such high level of agreement between the self-reported and
physician diagnoses suggests the utility of the patient’s self-
report as a valid proxy measure for these conditions. For
few conditions, where the agreement was relatively lower,
the patients might be having the disease in milder form or
initial stages and can perceive the symptoms though not
being detected by the treating physicians. Another plausible
explanation could be the fact that patients are not fully aware
of their prevailing illness despite having confirmed diagnosis.
The latter might be related to the lower health literacy as
majority of our patients had lower literacy [27]. Further
analysis into the predictors of concordancemight yield useful
insights.
4.1. Strengths and Limitations. Instruments contingent on
availability and accuracy of medical records may have lim-
ited utility for clinical and research purposes owing to
the deficient routine data management system in resource-
limited countries like India [28]. Given the understanding
that primary care practice characteristics in LMICs may not
be comparable with those of western countries, this work for
the first time has developed amultimorbidity assessment tool
and contextualized it for Indian primary care.
When compared to multimorbidity measurement meth-
ods available till date in LMICs, our approach and instrument
are scientifically superior in many aspects. The questionnaire
was generated through an iterative process of desk review and
chart review, translation, and cultural adaptation, pretested
with cognitive interviews including negotiation between the
primary care physicians and the research team. These steps
helped assure content and face validity. This is reflected by
the questionnaire displaying good psychometric properties
with Cronbach’s alpha and ICC indicating it to be internally
consistent and reliable in this setting. Furthermore, many of
the domains draw on already validated questionnaire which
reinforces the robustness.
Our MAQ-PC has positive features of being brief and
easily understandable by patients and at the same time
being comprehensive enough to include commonly prevalent
chronic conditions in primary care patients. Each question-
naire on an average took 20–25minutes to complete and thus
can easily be administered at outpatient setting either by a
physician or by other health care professionals. Employing
self-report allows identifyingmultimorbidity by simple count
and the results from the item scales can be easily scored and
readily interpretable. Moreover, the questionnaire enquires
about the treatment and limitations imposed by specific
diseases which can be used as a surrogate marker of the
severity of the disease.
However, some limitations need to be acknowledged
while using this MAQ-PC. It has been shown previously that
list of diseases reported on the basis of prescriptions may not
be fully accurate, as many conditions remain undiagnosed,
so using this method as the gold standard may not be ideal.
Additionally, with any questionnaire-based technique, there
is a potential for recall bias.Though patients had the option of
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mentioning any additional diseases that were not listed, it is
possible that patients may not recall milder forms of existing
comorbid diseases and this may inadvertently leave out some
important conditions. We did not elicit information on the
duration and order of appearance of individual diseases, thus
weakening our severity score. Our outcome assessment is not
comprehensive as it did not include health care expenditure
as we were apprehensive of time constraint and also our
primary objectivewas to examinemultimorbidity prevalence,
pattern, and health outcomes. Lastly, we have only examined
the appropriateness of questionnaire in primary care patients,
thus restricting the possibility of extrapolating to other
groups of patients like those attending more specialized care
andhaving complex patterns ofmultimorbidity.Despite these
limitations, we believe that MAQ-PC, being a reliable and
valid descriptor of individual chronic morbidities, has utility
as a tool for identifying and quantifying multimorbidity in
primary care.
4.2. Future Research Directions. Future studies need to exam-
ine the suitability of MAQ-PC to measure multimorbidity
in other outpatient care settings, where medical records are
unavailable. Further development of this questionnairemight
include specific enquiry about the duration and chronological
order of multiple chronic conditions and health care expen-
diture. Since the number of chronic diseases increases with
age and multimorbidity is a frequently observed geriatric
phenomenon, it is necessary to test the applicability of this
tool in geriatric population particularly.
5. Conclusion
To summarize, MAQ-PC is a comprehensive tool for obtain-
ing data on patient self-reported multimorbidity in primary
care. Our results demonstrate this questionnaire to be a valid
and reliablemeasure ofmultimorbidity in a variety of chronic
conditions and primary care patients. The instrument also
provides information on severity of the individual conditions
and impact on quality of life which suits the need in primary
care to identify patient groups that might benefit from more
coordinated and holistic care. We believe MAQ-PC may
find applicability in assessing multimorbidity and its impact,
following multimorbidity trajectory, designing therapeutic
targets across wide range of health care settings in India.
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